MEDNAX, Inc. (MD)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 633.63M |
| Enterprise value | 1.30B |
| Trailing P/E | N/A |
| Forward P/E | 5.84 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.31 |
| Price/book (mrq) | 0.74 |
| Enterprise value/revenue | 0.65 |
| Enterprise value/EBITDA | 69.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.59 |
| 52-week change 3 | -43.26% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 15.02 |
| 52-week low 3 | 7.26 |
| 50-day moving average 3 | 9.01 |
| 200-day moving average 3 | 10.35 |
Share statistics
| Avg vol (3-month) 3 | 763.75k |
| Avg vol (10-day) 3 | 1.11M |
| Shares outstanding 5 | 84.15M |
| Implied shares outstanding 6 | 84.15M |
| Float 8 | 81.59M |
| % held by insiders 1 | 1.55% |
| % held by institutions 1 | 106.65% |
| Shares short (30 Apr 2024) 4 | 4.67M |
| Short ratio (30 Apr 2024) 4 | 7.9 |
| Short % of float (30 Apr 2024) 4 | 7.92% |
| Short % of shares outstanding (30 Apr 2024) 4 | 5.56% |
| Shares short (prior month 28 Mar 2024) 4 | 4.12M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 20 Dec 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -3.53% |
| Operating margin (ttm) | 4.92% |
Management effectiveness
| Return on assets (ttm) | 4.24% |
| Return on equity (ttm) | -7.99% |
Income statement
| Revenue (ttm) | 2B |
| Revenue per share (ttm) | 24.24 |
| Quarterly revenue growth (yoy) | 0.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 189.71M |
| Net income avi to common (ttm) | -70.58M |
| Diluted EPS (ttm) | -0.12 |
| Quarterly earnings growth (yoy) | -71.60% |
Balance sheet
| Total cash (mrq) | 115.47M |
| Total cash per share (mrq) | 1.39 |
| Total debt (mrq) | 778.66M |
| Total debt/equity (mrq) | 90.94% |
| Current ratio (mrq) | 1.73 |
| Book value per share (mrq) | 10.36 |
Cash flow statement
| Operating cash flow (ttm) | 113.02M |
| Levered free cash flow (ttm) | 43.23M |
© 2024 Yahoo. All rights reserved.